Medtronic, Inc. Receives Approval for First Artificial Disc for the Neck in the United States

MEMPHIS, Tenn.--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) announced today that it has received U.S. Food and Drug Administration (FDA) approval to market the Prestige® Cervical Disc, the first artificial disc commercially available in the United States for use in the neck. The Prestige Cervical Disc gives some patients who suffer from degenerative disc disease, which can cause intolerable neck and/or arm pain, the potential to preserve motion at the treated level, as well as offer pain relief and function. Typically, a traditional motion-limiting spinal fusion procedure is indicated for these patients.